Harmon Cyrus sold OLMA
September 18, 2025 · Form 4 insider transaction
Harmon Cyrus sold 10,000 shares of Olema Pharmaceuticals, Inc. at $8.33 per share, a transaction worth $83.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$8.33
Total value
$83.3K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 18, 2025
Filing dateSeptember 18, 2025
Shares owned after744,140
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $8.33, and the range of prices was between $8.28 and $8.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.